Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
90.60
+3.39 (3.89%)
At close: May 20, 2026, 4:00 PM EDT
90.64
+0.04 (0.04%)
After-hours: May 20, 2026, 4:14 PM EDT
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Rhythm Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $138.2. The average 1-year stock price forecast is 52.54% higher than the current stock price, while the lowest is $105 (+15.89%) and the highest is $159 (+75.50%).
Price Target: $138.2 (+52.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $140 → $143 | Strong Buy | Maintains | $140 → $143 | +57.84% | May 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $136 → $137 | Buy | Maintains | $136 → $137 | +51.21% | May 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $143 → $144 | Buy | Maintains | $143 → $144 | +58.94% | May 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $105 | Strong Buy | Maintains | $100 → $105 | +15.89% | Mar 23, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $131 → $142 | Strong Buy | Maintains | $131 → $142 | +56.73% | Mar 20, 2026 |
Financial Forecast
Revenue This Year
294.24M
from 189.76M
Increased by 55.06%
Revenue Next Year
548.22M
from 294.24M
Increased by 86.32%
EPS This Year
-3.21
from -3.11
EPS Next Year
-0.68
from -3.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 315.1M | 653.2M | ||||||
| Avg | 294.2M | 548.2M | ||||||
| Low | 259.5M | 426.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 66.0% | 122.0% | ||||||
| Avg | 55.1% | 86.3% | ||||||
| Low | 36.7% | 44.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.60 | 1.79 | ||||||
| Avg | -3.21 | -0.68 | ||||||
| Low | -3.80 | -2.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.